Table 3

Comparison of pathologic tumour characteristics between the 2 groups, by tumour type

Characteristic; indicationGroup; mean ± SDp value
PRATLA
Gland size, cm
 All tumour types5.3 ± 1.56.2 ± 2.60.2*
 Excluding pheochromocytoma5.3 ± 1.46.0 ± 1.80.1
 Pheochromocytoma6.0 ± 2.1
n = 5
6.6 ± 3.30.6
 Primary aldosteronism5.2 ± 1.25.3 ± 2.10.9
 Cushing syndrome4.5 ± 1.58.0 ± 1.70.05
 Nonfunctional6.7 ± 1.56.0 ± 1.20.4
Gland weight, g
 All tumour types19.2 ± 13.963.4 ± 65.5< 0.001
 Excluding pheochromocytoma19.3 ± 14.464.5 ± 55.40.001
 Pheochromocytoma18.6 ± 9.7
n = 5
61.9 ± 80.00.02*
 Primary aldosteronism16.9 ± 12.638.0 ± 43.90.1
 Cushing syndrome16.4 ± 9.2132.0 ± 56.60.002*
 Nonfunctional35.2 ± 19.165.6 ± 48.90.3*
  • PRA = posterior retroperitoneoscopic adrenalectomy; SD = standard deviation; TLA = transperitoneal laparoscopic adrenalectomy.

  • * t test.

  • Wilcoxon rank-sum test.